Want to join the conversation?
$ZNGA's R&D expenses fell $21.7MM in 3Q15 compared to 3Q14. The decrease in R&D was primarily attributable to an $11.9MM decrease in headcount-related expense, $6.8MM of expense recorded in 3Q14 to reflect the change in estimated fair value of the contingent consideration liability for Spooky Cool Labs and a $2MM decrease in stock-based expense.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?